Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis

2019年冠状病毒病(COVID-19) 医学 萧条(经济学) 焦虑 人口 队列研究 流行病学 儿科 内科学 精神科 环境卫生 疾病 传染病(医学专业) 经济 宏观经济学
作者
De Luo,Bingjie Mei,Piao Wang,Xujia Li,Xinpei Chen,Gang Wei,Fei Kuang,Бо Ли,Song Su
出处
期刊:Clinical Microbiology and Infection [Elsevier BV]
卷期号:30 (3): 328-335 被引量:46
标识
DOI:10.1016/j.cmi.2023.10.016
摘要

Abstract

Background

Long-term physical and mental persistent symptoms after COVID-19 represent a growing global public health concern. However, there remains a substantial knowledge gap regarding their prevalence and risk factors.

Objectives

To estimate the prevalence and risk factors for persistent symptoms after COVID-19.

Methods of data synthesis

We used a random-effects model to pool persistent symptom prevalence and risk ratios comparing COVID-19 patients with non-COVID-19 individuals.

Data Sources

Electronic databases were searched for studies published from December 2019 to January 2023.

Study eligibility criteria

Eligible studies that reported the prevalence and risk factors for persistent symptoms after COVID-19 were included.

Participants

Patients who recovered from COVID-19.

Assessment of risk of bias

The Joanna Briggs Institute critical appraisal tool was used to assess the risk of bias in prevalence studies, whereas the risk of bias in cohort studies was evaluated with the Newcastle-Ottawa Scale.

Results

After screening 4359 studies, a total of 211 eligible studies were included, covering a population of 13 368 074 individuals. Fatigue, dyspnoea, post-traumatic stress disorder, anxiety, and depression were the most frequently reported persistent symptoms after COVID-19. Subgroup analyses revealed that individuals with more severe illness in the acute phase or from Europe exhibited a higher prevalence of certain symptoms, whereas children demonstrated a lower prevalence. Furthermore, COVID-19 patients had a significantly higher prevalence of most persistent symptoms compared with non-COVID-19 individuals. Factors frequently associated with a higher prevalence of persistent symptoms included female gender, advanced age, severe illness during the acute phase of COVID-19, multiple comorbidities, an extended duration of hospital stay, and a high body mass index.

Conclusion

This meta-analysis provides a thorough review of the prevalence and risk factors for persistent symptoms following COVID-19. The findings underscore the importance of long-term monitoring and support for individuals recovering from COVID-19.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Micheallee完成签到,获得积分10
2秒前
于归故城完成签到,获得积分10
2秒前
maggiexjl完成签到,获得积分10
2秒前
有魅力的桐完成签到 ,获得积分10
2秒前
JY完成签到,获得积分10
4秒前
小唐完成签到,获得积分10
4秒前
8R60d8应助blackbody采纳,获得10
4秒前
ATOM发布了新的文献求助50
5秒前
CJY完成签到 ,获得积分10
7秒前
可爱紫文完成签到 ,获得积分10
7秒前
DoyoUdo完成签到 ,获得积分10
8秒前
在水一方应助ATOM采纳,获得20
12秒前
阿然完成签到,获得积分10
12秒前
达达完成签到,获得积分10
12秒前
bcl完成签到,获得积分10
13秒前
激昂的如柏完成签到,获得积分10
13秒前
wmc1357完成签到,获得积分10
17秒前
aaa完成签到,获得积分20
17秒前
张群完成签到,获得积分10
19秒前
Hg铜完成签到,获得积分10
21秒前
litongkk完成签到 ,获得积分10
21秒前
诸葛烤鸭完成签到,获得积分10
22秒前
tmobiusx完成签到,获得积分10
25秒前
HY完成签到 ,获得积分10
25秒前
糖宝完成签到,获得积分10
26秒前
嘻嘻完成签到 ,获得积分0
27秒前
细心的语蓉完成签到,获得积分10
27秒前
菌了个菇完成签到 ,获得积分10
27秒前
aaa关闭了aaa文献求助
28秒前
安容完成签到 ,获得积分10
31秒前
32秒前
Jasper应助科研通管家采纳,获得10
32秒前
JamesPei应助科研通管家采纳,获得10
32秒前
笑点低歌曲完成签到,获得积分10
35秒前
tian完成签到,获得积分10
35秒前
36秒前
塘仔完成签到,获得积分10
38秒前
ATOM发布了新的文献求助20
41秒前
heiye完成签到,获得积分10
42秒前
caoxiongfeng_512完成签到,获得积分10
45秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Development Across Adulthood 800
Chemistry and Physics of Carbon Volume 18 800
The Organometallic Chemistry of the Transition Metals 800
The formation of Australian attitudes towards China, 1918-1941 640
Signals, Systems, and Signal Processing 610
天津市智库成果选编 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6444843
求助须知:如何正确求助?哪些是违规求助? 8258667
关于积分的说明 17592041
捐赠科研通 5504555
什么是DOI,文献DOI怎么找? 2901598
邀请新用户注册赠送积分活动 1878561
关于科研通互助平台的介绍 1718178